3-year results of a phase I/II single arm clinical trial of recombinant Bacillus Calmette-Guerin (BCG) VPM1002BC immunotherapy in non-muscle-invasive bladder cancer recurrence after conventional BCG therapy - SAKK 06/14
VPM1002BC
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: 3-year results of a phase I/II single arm clinical trial of recombinant Bacillus Calmette-Guerin (BCG) VPM1002BC immunotherapy in non-muscle-invasive bladder cancer recurrence after conventional BCG therapy - SAKK 06/14 ### Output: VPM1002BC